NHS diabetes prevention programme 2026: Is the NHS DPP working in the UK?

برنامج NHS للوقاية من السكري 2026: هل ينجح البرنامج؟

Author: Feras Alayed - Therapeutic & Behavioral Nutrition Specialist

Published:

Category: british-health

Reading Time: 11 minutes

Key Takeaways

  • The NHS Diabetes Prevention Programme (NHS DPP) is a national behavioural programme rolled out across England with similar prevention activity in Scotland, Wales and Northern Ireland; uptake and outcomes vary by region and population group (NHS England, Diabetes UK).
  • People with non‑diabetic hyperglycaemia (HbA1c 42–47 mmol/mol) or fasting plasma glucose in the prediabetes range are eligible; modest average weight loss (2–3 kg) and HbA1c reductions have been reported, which may lower progression to type 2 diabetes.
  • Independent evaluations show the NHS DPP reaches hundreds of thousands but faces inequalities in reach and completion — more work is needed to serve younger adults and deprived communities (NHS England, Public Health England).
  • Recent international systematic reviews and randomized trials (2021–2025) suggest structured lifestyle and digital programmes can reduce progression to diabetes; combining in-person and digital options tends to improve reach.
  • Feel Great (Balance, Unimate, 4-4-12 protocol) is not a medication but may offer a structured lifestyle-support approach that complements NHS advice and the DPP by helping with post‑meal glucose responses, energy and fasting adherence.

TL;DR

The NHS diabetes prevention programme 2026 has expanded reach and modest clinical outcomes (average HbA1c and weight reductions). It appears to slow progression to type 2 diabetes for many participants, but inequalities in access and long‑term maintenance remain challenges. NHS and NICE guidance still emphasise structured lifestyle change and personalised support — the DPP is useful but not a complete solution.

🇬🇧 Want to take action now? Try Feel Great → | Chat with a coach →

Introduction — a shocking UK statistic

More than 6.5 million people in the UK are estimated to have non-diabetic hyperglycaemia (prediabetes) or be at high risk of developing type 2 diabetes, while around 4.3 million people are living with diagnosed diabetes (Diabetes UK). That means millions are in the window where prevention can make a difference. The NHS Diabetes Prevention Programme (NHS DPP) was scaled up across England from 2016 to 2026 to act on this opportunity — but is it working?

What is the NHS Diabetes Prevention Programme (DPP)?

The NHS DPP is a behavioural, evidence-based programme commissioned nationally in England that offers structured lifestyle support to people identified with non‑diabetic hyperglycaemia (HbA1c 42–47 mmol/mol) or equivalent fasting glucose thresholds. The programme includes group education, dietary advice, physical activity support and behaviour change techniques. Referral routes include general practice (GP), NHS Health Checks and other NHS services; the programme complements NHS clinical care rather than replacing GP oversight (NHS England, NHS.uk).

Eligibility and clinical thresholds

  • Non‑diabetic hyperglycaemia (HbA1c 42–47 mmol/mol) — per NICE and NHS definitions.
  • Impaired fasting glucose thresholds are often used by local services (typical ranges 5.6–6.9 mmol/L depending on criteria).

These thresholds define the group most often offered the DPP referral (NICE and NHS guidance).

How widely delivered across the UK?

The NHS DPP is delivered nationally across England (commissioned by NHS England). Devolved nations have similar prevention activity but different delivery models: NHS Scotland, NHS Wales and Health and Social Care Northern Ireland operate local programmes or pathways aligned with NICE recommendations and local public health priorities. The result: coverage varies by nation and by local authority within England (NHS England, Public Health England reports).

What outcomes are reported? — Real numbers (mmol/L and mmol/mol)

Independent and NHS evaluations report average short‑term outcomes for participants who complete the programme:

  1. Average weight change: typically 2–4 kg loss at 6–12 months for completers.
  2. Average HbA1c change: mean reductions of around 1–3 mmol/mol in many reports; participants often move toward the lower end of the non‑diabetic hyperglycaemia range (42–47 mmol/mol).
  3. Fasting glucose: modest decreases of ~0.1–0.3 mmol/L in several UK service evaluations.

These changes are smaller than those seen in tightly‑controlled RCTs with intensive interventions but are clinically meaningful at population scale because even modest weight loss and HbA1c reductions are associated with lower progression risk (NHS England evaluation; Diabetes UK reviews; NICE evidence summaries).

What does the evidence say? (UK and international)

Studies and systematic reviews in the last five years give us a clearer picture:

  • Real‑world UK evaluations (NHS England and independent Public Health England reports) show positive short-term outcomes but highlight varying uptake by age, ethnicity and deprivation.
  • International systematic reviews and meta‑analyses (Lancet, BMJ, Cochrane) suggest structured lifestyle programmes reduce progression to type 2 diabetes compared with usual care; digital and hybrid programmes show promise for wider reach.

Representative references are in the References section below (NHS England, Diabetes UK, NICE, Cochrane, Lancet and BMJ reviews).

Strengths of the NHS DPP

  1. Scale: national commissioning in England allows consistent access through GP referral and NHS checks (NHS England).
  2. Evidence-based content: structured behaviour-change, nutrition and activity guidance aligned with NICE.
  3. Flexibility: in recent years the DPP has added digital and remote options, improving accessibility for some groups.

Limitations and challenges

  1. Inequality in reach and completion: younger adults, men and people in deprived areas are less likely to be referred or complete the programme (NHS evaluation, Public Health England).
  2. Variable engagement: average weight and HbA1c changes are modest — maintaining change long term is difficult.
  3. Data gaps: long‑term follow-up (beyond 3–5 years) and outcomes by ethnicity and socioeconomic group need stronger evidence.

Comparison table: NHS DPP vs typical RCT diabetes prevention programmes

FeatureNHS DPP (real-world)Typical RCT intensive programme
SettingCommunity, primary care, digitalClinical trial centres, highly controlled
Average weight loss (6–12 months)2–4 kg5–7+ kg
HbA1c change~1–3 mmol/mol~3–8 mmol/mol
ReachWide population reach; variable uptakeSelected, motivated volunteers
Long-term maintenanceVariable; limited data beyond 3 yearsOften better within trial support; fades when support withdrawn

How cost-effective is the programme?

Economic modelling used in NHS planning suggests that lowering progression to type 2 diabetes reduces future NHS costs from complications (cardiovascular disease, renal disease). Cost-effectiveness improves when high-risk people complete the programme and sustain weight loss. However, inequalities in uptake reduce overall population impact (NICE and NHS economic assessments).

How the NHS DPP aligns with NICE guidelines

NICE guidance recommends offering structured education and weight‑loss-focused lifestyle interventions to people with non‑diabetic hyperglycaemia, and the NHS DPP is explicitly designed to meet these aims. NICE also highlights the importance of tailoring interventions for different population groups and monitoring outcomes (NICE guidelines and public health guidance).

Practical takeaways for patients and clinicians

  1. GPs should continue to identify people with HbA1c 42–47 mmol/mol (non‑diabetic hyperglycaemia) and offer DPP referral as part of routine care.
  2. Patients who are eligible should consider joining — even modest weight loss and lowering HbA1c by a few mmol/mol can reduce risk of progression.
  3. If local DPP options are limited, ask your GP about digital or hybrid options, NHS Health Checks, local public health programmes, or community-based lifestyle services.

How Feel Great helps — where it fits

As a behavioural nutrition specialist and founder of the Health Investor concept, I present Feel Great as a lifestyle support system — not a medication. Feel Great combines a soluble-fibre matrix called Balance (which may help moderate post‑meal glucose responses by slowing carbohydrate absorption), Unimate (a yerba mate extract containing chlorogenic acids for energy and mental clarity), and the 4-4-12 intermittent fasting protocol to support consistent eating patterns.

How this links to the NHS DPP and diabetes prevention:

  • Complementary approach: Feel Great is designed to be used alongside NHS advice, GP care and structured prevention programmes — it may support dietary adherence and fasting windows that many DPPs emphasise.
  • Post‑meal glucose management: Balance's soluble fibre matrix may help reduce post‑prandial glucose spikes, which is relevant for people with HbA1c in the 42–47 mmol/mol range (lab values and personal monitoring should be discussed with your healthcare team).
  • Behavioural support: combining discreet, evidence-informed tools (product + protocol + coaching) can improve adherence to lifestyle changes promoted in the NHS DPP.

Important: Feel Great is not a medicine and should not replace GP advice or NHS programmes. Discuss any use with your GP, particularly if you take medications or have coexisting conditions. The Feel Great system references 50+ clinical studies listed in the PDR for its components; these are supportive data rather than clinical claims.

Who benefits most — evidence-based targeting

Evidence suggests that participants who lose ≥5% body weight and increase physical activity show the greatest reductions in diabetes incidence. The DPP seeks to achieve behaviour change that leads to such results; combining programme participation with lifestyle supports like structured meal timing, soluble fibre and consistent activity may improve outcomes for some people (see international meta-analyses and NHS evaluations).

People Also Ask

  1. Is the NHS Diabetes Prevention Programme available near me?
    Yes — in England you can be referred by your GP or check the NHS DPP pages. Scotland, Wales and Northern Ireland offer local prevention pathways through their NHS services.
  2. Will the programme change my HbA1c from 45 mmol/mol to normal?
    Some people do reduce HbA1c into the normal range (<42 mmol/mol), but average changes are modest; individual results vary with engagement and weight loss.
  3. Can I do the DPP online?
    Yes. The NHS DPP now includes digital and hybrid options for many areas.
  4. Does it cost money?
    The NHS‑commissioned DPP is free at the point of delivery when offered via NHS referral in England; check local arrangements in other UK nations and private options if preferred.
  5. How long does the programme last?
    Most programmes run over several months (commonly 9–12 months of contact with intensive sessions early on and follow-up support).

FAQ

  1. How do I know if I have non‑diabetic hyperglycaemia?
    Ask your GP for an HbA1c test. Non‑diabetic hyperglycaemia is usually HbA1c 42–47 mmol/mol. Fasting plasma glucose thresholds are used in some settings.
  2. Can lifestyle change reverse prediabetes?
    Lifestyle change can lower the risk of progression and in many cases return blood glucose markers toward normal — outcomes depend on weight loss, sustained activity and dietary changes.
  3. Is the DPP safe for older adults?
    Yes. Programmes are adapted to individual needs; tell your GP about mobility, medications or other concerns.
  4. What if I don’t finish the programme?
    Even partial participation can provide benefits, but completion maximises chances of sustained change. Ask your provider about flexible options.
  5. How does the NHS measure success?
    Common measures include weight, HbA1c (mmol/mol), fasting glucose (mmol/L), and service-level metrics like referrals, attendance and completion.

Practical checklist: If you’re eligible

  1. Book an appointment with your GP to confirm HbA1c and discuss DPP referral.
  2. If offered, accept the referral — ask about digital/hybrid options if schedule or travel is a barrier.
  3. Set small goals (1–2% bodyweight initially) and track HbA1c and weight changes with your GP.
  4. Discuss complementary lifestyle supports (e.g., higher soluble fibre, consistent meal timing, supervised exercise) with a clinician before starting any product.

Conclusions — is it working?

The NHS diabetes prevention programme 2026 is a meaningful national effort. It is working in the sense that it reaches large numbers, is evidence-informed and produces modest but relevant metabolic improvements for completers. However, inequalities in access and challenges with long‑term maintenance reduce maximal population impact. The best strategy is a mixed approach: promote broad access (including digital options), target high‑risk and underserved groups, and offer complementary lifestyle supports such as structured fibre intake, energy-management tools, and behavioural protocols like 4-4-12 fasting — always under NHS supervision.

References & Scientific Sources

  1. NHS — Preventing type 2 diabetes. NHS.uk. https://www.nhs.uk/conditions/type-2-diabetes/preventing-type-2-diabetes/ (accessed 2026)
  2. NHS England — NHS Diabetes Prevention Programme. https://www.england.nhs.uk/diabetes/diabetes-prevention/ (accessed 2026)
  3. Diabetes UK — Key statistics about diabetes. https://www.diabetes.org.uk/about_us (accessed 2026)
  4. Public Health England — NHS DPP: first three years independent evaluation. https://www.gov.uk/government/publications/nhs-diabetes-prevention-programme-first-three-years (accessed 2026)
  5. British Heart Foundation — Heart and circulatory disease statistics (relating to diabetes risk). https://www.bhf.org.uk/what-we-do/our-research/heart-statistics (accessed 2026)
  6. NICE — Behaviour change and diabetes prevention guidance. https://www.nice.org.uk (search: type 2 diabetes prevention guidance) (accessed 2026)
  7. Cochrane Review — Lifestyle interventions for preventing type 2 diabetes (Cochrane Library). https://www.cochranelibrary.com (search: diabetes prevention lifestyle) (accessed 2026)
  8. Lancet / BMJ systematic reviews on diabetes prevention and digital interventions (selected recent reviews 2021–2025). Examples: Lancet Diabetes Endocrinol; BMJ. (Search PubMed for recent meta-analyses: https://pubmed.ncbi.nlm.nih.gov/ )
  9. Major RCTs and follow-ups (Diabetes Prevention Program Research Group; long-term outcomes). NEJM; Diabetes Care archives.
  10. Recent UK real-world analyses of the NHS DPP and digital adaptations (NHS England evaluation reports 2019–2024).

Note: the References above point to authoritative UK and international sources; for specific trial-by-trial details see PubMed and journal links. Numbers quoted (HbA1c thresholds of 42–47 mmol/mol, fasting glucose in mmol/L, average weight loss) reflect aggregated UK programme reports and international reviews.

Medical Disclaimer

This article is for information only and does not replace professional medical advice. Talk to your GP before making changes to medication, diet, exercise or before starting any new supplement or programme. The Feel Great system is a lifestyle support tool and is not a medication.

🇬🇧 Ready to Start Your Health Transformation?

Join thousands across United Kingdom who have improved their metabolic health with the Feel Great system. Backed by 50+ clinical studies and listed in the Physicians' Desk Reference (PDR).

🛒 Order Feel Great — Free Delivery Across England, Scotland, Wales & Northern Ireland 💬 Chat with a Health Coach 📋 Take Free Health Assessment ⭐ View Success Stories

✅ Free Delivery Across England, Scotland, Wales & Northern Ireland | 90-Day Money-Back Guarantee

النقاط الأساسية

  • برنامج NHS للوقاية من السكري متاح على نطاق واسع في إنجلترا مع مسارات موازية في إسكتلندا وويلز وأيرلندا الشمالية؛ النتائج متفاوتة حسب المنطقة والمجموعة السكانية (NHS England، Diabetes UK).
  • المستهدفون هم الأشخاص ذوو فرط سكر الدم غير السكري (HbA1c 42–47 mmol/mol) أو القيم الصيامية المرتفعة؛ تقارير البرنامج تُظهر خسارة وزن متوسطة 2–4 كجم وانخفاضات متواضعة في HbA1c.
  • التقييمات المستقلة تشير إلى وصول مئات الآلاف لكن ثمة فجوات وتأثيرات على الفئات الشابة والأكثر حرمانًا.
  • الأدلة الدولية الحديثة (2021–2025) تُظهر أن البرامج المنظمة، بما في ذلك الرقمية، قد تُقلل من تقدم حالة ما قبل السكري إلى النوع 2.
  • نظام Feel Great ليس دواءً لكنه قد يساعد كنظام دعم نمط حياة متمم لإرشادات NHS وDPP من خلال المكونات والسلوكيات المهيكلة.

TL;DR

برنامج NHS للوقاية من السكري 2026 مُوسع وله نتائج سريرية معتدلة لدى المشاركين المكتملين. يعمل على خفض مخاطر التطور إلى داء السكري لكن لا يزال يواجه تحديات وصول ومتابعة طويلة الأمد. الإرشادات الوطنية من NICE تواصل التأكيد على التغيير السلوكي والدعم المخصص.

🇬🇧 هل تريد اتخاذ خطوة الآن؟ جرب Feel Great ← | تحدث مع مدرب ←

مقدمة — إحصائية صادمة للمملكة المتحدة

يوجد ملايين الأشخاص في المملكة المتحدة في حالة ما قبل السكري أو في خطر مرتفع للإصابة بداء السكري النوع 2؛ يُقدّر عدد المصابين بالسكري المشخّص بنحو 4.3 مليون شخص (Diabetes UK). هذا يعني نافذة حقيقية للوقاية — وهو الهدف الذي يسعى إليه برنامج NHS للوقاية من السكري.

ما هو برنامج NHS للوقاية من السكري؟

هو برنامج سلوكي منظم في إنجلترا يقدّم دعما تعليمياً وتغييريًا للأشخاص ذوي فرط سكر الدم غير السكري (HbA1c 42–47 mmol/mol). يشمل محتوى غذائيًا، نشاطًا بدنيًا وتقنيات تغيير سلوكي. يمكن الإحالة عبر طبيب الأسرة (GP) أو فحص NHS Health Check، والبرنامج مُكمّل للرعاية الطبية وليس بديلاً عنها (NHS England، NHS.uk).

معايير الأهلية والقيم السريرية

  • فرط سكر الدم غير السكري: HbA1c 42–47 mmol/mol (تعريف NICE/NHS).
  • بعض خدمات الرعاية تستخدم قيم الجلوكوز الصائم (عادة نطاقات 5.6–6.9 mmol/L حسب المعايير المحلية).

مدى التغطية عبر المملكة المتحدة

البرنامج مُموّل وطنيًا في إنجلترا. لدى إسكتلندا وويلز وأيرلندا الشمالية برامج موازية أو مسارات محلية للوقاية من السكري تتوافق مع إرشادات NICE ومتطلبات الصحة العامة المحلية. بالتالي، تختلف التغطية والطرائق حسب الأمة والسلطة المحلية (NHS England، Public Health England).

ما هي النتائج المبلغ عنها؟ — أرقام حقيقية (mmol/L و mmol/mol)

التقارير تتحدث عن نتائج قصيرة المدى لدى المكتملين:

  1. خسارة الوزن: عادة 2–4 كجم خلال 6–12 شهرًا.
  2. تغيير HbA1c: انخفاض متوسط بين 1–3 mmol/mol في العديد من التقارير؛ البعض يقترب من حد <42 mmol/mol.
  3. الجلوكوز الصائم: انخفاضات طفيفة ~0.1–0.3 mmol/L.

هذه التغييرات متواضعة مقارنةً ببعض دراسات التجارب السريرية لكنها مهمة عند النظر إلى تأثيرها على مستوى السكان؛ حتى انخفاضات بسيطة في الوزن وHbA1c يمكن أن تخفض خطر التقدّم إلى مرض السكري.

ماذا تقول الأدلة؟ (بريطانيا ودوليًا)

الأدلة الحديثة تشير إلى ما يلي:

  • التقييمات الحقلية في المملكة المتحدة تُظهر فوائد قصيرة المدى لكنها تكشف عن فروق في الوصول والإكمال حسب العمر والمجتمع.
  • المراجعات المنهجية والدراسات العشوائية الحديثة (Lancet، BMJ، Cochrane وغيرها) تدعم فائدة البرامج المهيكلة في تقليل تقدم ما قبل السكري لسكري النوع 2، مع أثر ملموس للخيارات الرقمية على التوسّع.

نِقاط القوة

  1. المدى: إحالة موحدة عبر الخدمات الصحية في إنجلترا تتيح نطاقًا واسعًا.
  2. المحتوى المبني على الأدلة: تعليم سلوكي وتغذية ونشاط متوافق مع NICE.
  3. المرونة: خيارات رقمية ومختلطة زادت الوصول لعدد من الأشخاص.

التحديات

  1. عدم المساواة في الوصول والإكمال (الشباب، الرجال، الفئات الأكثر حرمانًا).
  2. صعوبة الحفاظ على التغيّر طويل الأمد بعد انتهاء الدعم المباشر.
  3. نقص بيانات متابعة طويلة الأمد مفصّلة بحسب العرق والوضع الاجتماعي.

مقارنة: برنامج NHS DPP مقابل برامج التجارب العشوائية المكثفة

الميزةبرنامج NHS DPP (الواقع)برنامج RCT المكثف
الإعدادمجتمع/رعاية أولية/رقميمراكز تجريبية وخاضعة للرقابة
خسارة الوزن المتوسطة2–4 كجم5–7+ كجم
تغيير HbA1c~1–3 mmol/mol~3–8 mmol/mol
المدىواسع لكن متقلبمحدود إلى متطوعين
الاستدامة طويلة الأمدمتغيرةأحيانًا أفضل داخل الدعم التجريبي

كيف يساعد Feel Great — أين يندرج؟

نظام Feel Great هو نظام دعم نمط حياة (ليس دواءً). يجمع بين Balance — مصفوفة ألياف قابلة للذوبان قد تساهم في تخفيف ارتفاعات السكر بعد الوجبات — وUnimate (مستخلص يربا ماتي يحتوي على أحماض كلوروجينية مما قد يعزز اليقظة والطاقة) وبروتوكول 4-4-12 للصيام المتقطع. يمكن استخدامها بجانب DPP وأدلة NHS كأدوات مساعدة لسلوكيات التغذية والالتزام.

تذكير مهم: ناقش أي استخدام مع طبيبك، لا بد أن يكون ذلك تحت إشراف إذا كنت تتناول أدوية أو لديك حالات مرضية.

نصائح عملية للمصابين بحالة ما قبل السكري

  1. اطلب اختبار HbA1c من GP وتأكد من نتائجك (42–47 mmol/mol تتطلب النظر في إحالة DPP).
  2. اقبل الإحالة إلى DPP إن عُرضت، وخاصة إن كانت هناك خيارات رقمية أو حضورية مناسبة لجدولك.
  3. حدد أهدافًا صغيرة قابلة للتحقيق: فقدان 5% من الوزن له تأثير واضح على المخاطر.
  4. اطلب دعمًا مستمرًا: مجموعات، خدمات محلية، أدوات سلوكية أو دعم رقمي للحفاظ على التغيير.

الخلاصة

برنامج NHS للوقاية من السكري 2026 هو تدخل هام وواسع النطاق له فوائد مثبتة على مستوى الأفراد والمجتمع، لكنه ليس حلاً كاملاً. يتطلب تحسين الوصول، تقليل الفوارق والبحث عن طرق لتعزيز الصمود طويل الأمد. دمج مسارات رقمية، دعم مجتمعي، وأدوات مساعدة نمط الحياة مثل Feel Great قد يرفع الفعالية دون استبدال الإرشاد الطبي. تحدث مع GP قبل أي تغييرات.

المراجع والمصادر العلمية

  1. NHS — Preventing type 2 diabetes. https://www.nhs.uk/conditions/type-2-diabetes/preventing-type-2-diabetes/ (تم الاطلاع 2026)
  2. NHS England — NHS Diabetes Prevention Programme. https://www.england.nhs.uk/diabetes/diabetes-prevention/ (تم الاطلاع 2026)
  3. Diabetes UK — Facts and stats. https://www.diabetes.org.uk/about_us (تم الاطلاع 2026)
  4. Public Health England — NHS DPP: first three years evaluation. https://www.gov.uk/government/publications/nhs-diabetes-prevention-programme-first-three-years (تم الاطلاع 2026)
  5. British Heart Foundation — Heart statistics and diabetes links. https://www.bhf.org.uk/what-we-do/our-research/heart-statistics (تم الاطلاع 2026)
  6. NICE — Guidance on prevention of type 2 diabetes and behaviour change. https://www.nice.org.uk (ابحث عن إرشادات NICE ذات الصلة) (تم الاطلاع 2026)
  7. Cochrane Library — Reviews on lifestyle interventions for diabetes prevention. https://www.cochranelibrary.com (تم الاطلاع 2026)
  8. مراجعات منهجية ودراسات دولية في Lancet وBMJ وJAMA حول برامج الوقاية من السكري والخيارات الرقمية (راجع PubMed للنسخ الحديثة 2021–2025). https://pubmed.ncbi.nlm.nih.gov/ (تم الاطلاع 2026)

إخلاء طبي

هذا المحتوى لأغراض المعلومات العامة فقط ولا يُعد نصيحة طبية شخصية. استشر GP قبل بدء أي منتج أو تغيير علاجى. نظام Feel Great هو نظام دعم نمط حياة وليس دواءً.

🇬🇧 هل أنت مستعد لبدء تحولك الصحي؟

انضم لآلاف الأشخاص في بريطانيا الذين حسّنوا صحتهم الأيضية مع نظام Feel Great. مدعوم بأكثر من 50 دراسة سريرية.

🛒 اطلب Feel Great الآن 💬 تحدث مع مدرب صحي 📋 تقييم صحي مجاني

Frequently Asked Questions

What is the NHS diabetes prevention programme?

The NHS DPP is a structured, NHS‑commissioned lifestyle programme for people with non‑diabetic hyperglycaemia (HbA1c 42–47 mmol/mol), offering education on diet, activity and behaviour change, with in-person and digital options.

Who is eligible for the NHS DPP?

People identified with HbA1c 42–47 mmol/mol (non‑diabetic hyperglycaemia) or equivalent impaired fasting glucose ranges are typically eligible; referral routes include GP and NHS Health Checks.

Does the NHS DPP reduce HbA1c?

On average participants who complete the programme show modest HbA1c reductions (~1–3 mmol/mol) and weight loss (2–4 kg), which may reduce risk of progression to type 2 diabetes.

Is the NHS DPP free?

The NHS‑commissioned DPP is free at the point of care in England when referred via NHS routes; check local arrangements in Scotland, Wales and Northern Ireland.

Can I use Feel Great alongside the NHS DPP?

Feel Great is a lifestyle support system (Balance, Unimate, 4-4-12 protocol) and may be used as a complementary tool alongside NHS programmes, but not as a substitute for medical advice; consult your GP first.